Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (611-620 of 755) with videos related to

Pageof 76
Sort By:
Annals of the Rheumatic Diseases|January 18, 2023
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantationBurcu Ayoglu, Michele Donato, Daniel E Furst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Water Research|October 2, 2025
Transit times link pollution sources to drinking water quality in a "One Water" systemShantanu V Bhide, Stanley B Grant, Paolo Benettin, et al.
Arthritis and Rheumatism|May 1, 1983
Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trialH J Williams, J R Ward, J C Reading, et al.
The European Respiratory Journal|March 31, 2010
Systemic sclerosis and bilateral lung transplantation: a single centre experienceR Saggar, D Khanna, D E Furst, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupJ Avouac, J Fransen, U A Walker, et al.
Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2004
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, Zhao Zhao, Eugene Lin, et al.
Annals of the Rheumatic Diseases|December 1, 1999
Access to disease modifying treatments for rheumatoid arthritis patientsD E Furst, F C Breedveld, G R Burmester, et al.
Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.
Pageof 76

Showing results (611-620 of 755) with videos related to

Sort By:
Pageof 76
Annals of the Rheumatic Diseases|January 18, 2023
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantationBurcu Ayoglu, Michele Donato, Daniel E Furst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Water Research|October 2, 2025
Transit times link pollution sources to drinking water quality in a "One Water" systemShantanu V Bhide, Stanley B Grant, Paolo Benettin, et al.
Arthritis and Rheumatism|May 1, 1983
Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trialH J Williams, J R Ward, J C Reading, et al.
The European Respiratory Journal|March 31, 2010
Systemic sclerosis and bilateral lung transplantation: a single centre experienceR Saggar, D Khanna, D E Furst, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupJ Avouac, J Fransen, U A Walker, et al.
Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2004
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, Zhao Zhao, Eugene Lin, et al.
Annals of the Rheumatic Diseases|December 1, 1999
Access to disease modifying treatments for rheumatoid arthritis patientsD E Furst, F C Breedveld, G R Burmester, et al.
Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.
Pageof 76